Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,865 | -6,444 | -6,331 | -5,650 | -3,603 |
| Depreciation Amortization | 4,145 | 4,903 | 8,280 | 5,328 | 4,606 |
| Accounts receivable | -5,243 | -1,943 | 3,405 | -6,116 | 5,500 |
| Other Working Capital | 2,163 | 1,293 | 4,635 | 10,440 | 8,180 |
| Other Operating Activity | 6,732 | 1,579 | -3,895 | 4,451 | -8,342 |
| Operating Cash Flow | $4,933 | $-612 | $6,094 | $8,453 | $6,342 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -98 | -67 | -281 | -102 | -104 |
| Net Acquisitions | N/A | N/A | N/A | -13,500 | N/A |
| Purchase Of Investment | -2,477 | 0 | N/A | N/A | -200 |
| Purchase Sale Intangibles | -84 | -113 | -172 | -1,972 | -251 |
| Other Investing Activity | -2,131 | 124 | 176 | -72 | -198 |
| Investing Cash Flow | $-4,707 | $58 | $-106 | $-13,675 | $-502 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 38,489 | 31,475 | 52,900 | 59,000 |
| Debt Repayment | -10,035 | -35,997 | -34,891 | -51,700 | -59,000 |
| Common Stock Issued | 5,266 | 0 | N/A | N/A | N/A |
| Common Stock Repurchased | -264 | -579 | -741 | -1,053 | -1,387 |
| Other Financing Activity | -1,713 | -1,716 | -3,268 | -2,209 | -2,167 |
| Financing Cash Flow | $-6,746 | $197 | $-7,425 | $-2,062 | $-3,554 |
| Beginning Cash Position | 17,964 | 18,322 | 19,758 | 27,041 | 24,754 |
| End Cash Position | 11,445 | 17,964 | 18,322 | 19,758 | 27,041 |
| Net Cash Flow | $-6,520 | $-357 | $-1,436 | $-7,283 | $2,287 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,933 | -612 | 6,094 | 8,453 | 6,342 |
| Capital Expenditure | -98 | -67 | -281 | -102 | -104 |
| Free Cash Flow | 4,835 | -679 | 5,813 | 8,351 | 6,239 |